What’s new in Flare™ V12: significant enhancements to FEP and structure-based methods Online July 16, 2026 Lauren Nelson July 16, 2026 Read More
Modality Agnostic Drug Discovery Strategies for Data Sparse Targets Location June 11, 2026 Cresset Group June 11, 2026 Read More
Discovery and development of EP652, A METTL3 Inhibitor with efficacy in liquid and Solid Tumour Models Martin Slater February 19, 2026 Read More
Computational approaches to prioritize macrocyclic designs for synthesis Natercia Braz January 21, 2026 Read More
Getting the Most from Flare’s AI Copilots – Tips and Insights Mutlu Dogruel December 10, 2025 Read More
A Free Energy Perturbation (FEP) study: Identifying ‘new’, active ligands for TYK2 Lauren Nelson October 22, 2025 Read More
A collaborative lead optimization workflow for computational and medicinal chemists Lauren Nelson June 10, 2025 Read More
Using the new features in Flare™ V10 to help identify the molecules that matter for your project Stuart Firth-Clark March 25, 2025 Read More
Active learning FEP using 3D-QSAR for prioritizing bioisosteres in medicinal chemistry Venkat Raamaswamy February 27, 2025 Read More
Combating antibiotic resistance through ligand- and structure-based virtual screening Oliver Hills December 3, 2024 Read More